974MO 5-year update from KEYNOTE-407: Pembrolizumab plus chemotherapy in squamous non-small cell lung cancer (NSCLC)
Samantha Novello, Dariusz M. Kowalski, Alexander Luft, M. Gumus, David Vicente Baz, Julien Mazières, Jerónimo Rodríguez Cid, Ali Tafreshi, Y. Cheng, K.H. Lee, Alexander Golf, S. Sugawara, Andrew Robinson, B. Halmos, E. Jensen, Paul Schwarzenberger, M. Catherine Pietanza, L. Paz-Ares
Topics & Concepts
MedicinePlaceboInternal medicinePopulationPembrolizumabOncologyLung cancerCancerAlternative medicineImmunotherapyEnvironmental healthPathologyCancer Immunotherapy and BiomarkersLung Cancer Research StudiesBrain Metastases and Treatment